Timothy Bitsberger Buys Shares of CME Group
CME Group insider Timothy Bitsberger purchased 645 shares for $145,125.
Key Points
- Timothy Bitsberger bought 645 shares of CME Group Inc. at $225 per share, totaling $145,125 on June 25, 2026.
- CME Group Inc. trades on NasdaqGS with a market cap of $79.85 billion and a P/E ratio of 18.87.
- Rothschild & Co upgraded CME Group to 'buy' with a $323 target on June 11, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Timothy Bitsberger, an insider at CME Group Inc., recently purchased 645 shares of the company. The transaction, which took place on June 25, 2026, was valued at $145,125, with each share priced at $225. This purchase was not part of a pre-planned trading strategy.
Other Institutional Activity in CME Group
BlackRock, Inc. grew its holdings in CME Group by 370,381 shares, ending with 31,448,257 shares valued at approximately $9.29 billion, reflecting a 1.2% increase. Meanwhile, Vanguard Capital Management LLC opened a new position with 23,367,282 shares worth about $6.90 billion. State Street Corp trimmed its stake by 89,238 shares, resulting in 16,055,287 shares valued at $4.74 billion, a 0.6% decrease. JPMorgan Chase & Co added 1,108,304 shares, totaling 12,209,761 shares with a value of $3.63 billion, marking a 10% increase. Morgan Stanley also increased its holdings by 1,043,692 shares, bringing its total to 9,406,843 shares worth $2.78 billion, a 12.5% rise.
CME Group Inc. Stock Down 23.5%
Shares of NasdaqGS:CME traded near $218.58 on Tuesday. CME Group has a market capitalization of $79.85 billion and a P/E ratio of 18.87. The stock has a 52-week low of $220.73 and a high of $329.16, with a 50-day moving average of $273.98 and a 200-day moving average of $280.89. The company's beta is 0.244, indicating lower volatility compared to the broader market.
$CME stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
CME Group reported revenue of $6.74 billion, reflecting a growth rate of 14.4%. The company's net margin stands at 63.32%, with a return on equity of 15.92%. Earnings per share (EPS) are $11.71. The next earnings report is scheduled for July 22, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group offers an annual dividend rate of $5.20, yielding 2.35%. The dividend payout ratio is 95.56%, indicating the proportion of earnings paid out as dividends.
Insider Buying and Selling at CME Group Inc.
On June 25, 2026, several insiders, including Phyllis Lockett, Howard Siegel, William Shepard, Rahael Seifu, Timothy Bitsberger, and Bryan Durkin, each purchased 645 shares of CME Group at $225 per share. These transactions were not part of planned trading programs.
Analysts Set New Price Targets
On June 11, 2026, Rothschild & Co upgraded CME Group to a 'buy' rating with a price target of $323. Morgan Stanley and Barclays maintained their ratings, with targets of $353 and $316, respectively, from earlier in the year. The consensus among 15 analysts is a 'buy' recommendation, with an average price target of $302.60.
About CME Group Inc.
CME Group Inc., headquartered in Chicago, Illinois, operates markets for trading futures and options worldwide. It provides products based on interest rates, equity indexes, foreign exchange, and various commodities. The company also offers clearing house services and market data services to a broad range of clients, including professional traders, financial institutions, and central banks. Led by CEO Terrence A. Duffy, CME Group employs about 3,875 people.
Bottom Line
Timothy Bitsberger's recent purchase of CME Group shares highlights ongoing insider interest in the company. CME Group's robust market presence and recent analyst upgrades suggest continued investor attention. However, as a reminder, insider transactions are reported after the fact and may not indicate future performance.
Get CME Group Inc. alerts
New 13F filings, insider trades, and analyst moves on $CME, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.